JAZIEL CHAVIRA: Open Payments
NPI 1114535903 · STERLING, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,781 in 109 payments from 10 companies in 2025. Trend: 2023 $1,074 · 2024 $1,437 · 2025 $1,781
Food & beverage: $1,746Education: $35
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 35 | $647 |
| ABBVIE INC. | 25 | $263 |
| Madrigal Pharmaceuticals | 10 | $220 |
| Aimmune Therapeutics, Inc. | 14 | $178 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 9 | $176 |
| Gilead Sciences, Inc. | 8 | $139 |
| Ipsen Biopharmaceuticals, Inc | 3 | $80 |
| Lilly USA, LLC | 1 | $30 |
| Phathom Pharmaceuticals, Inc. | 3 | $27 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $23 |
Products named: TREMFYA, REZDIFFRA, XIFAXAN, ZENPEP, RINVOQ, SKYRIZI, IQIRVO, MAVYRET.
Industry payments across IL — which companies pay providers there.
